Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients With HER2 Amplified Breast Cancer
Observational
Observational Model: Case-Only, Time Perspective: Prospective
Comparison of expression levels of PTEN prior to treatment with HER2-targeting agents with levels after disease progression/recurrence
3 years
No
Sarat Chandarlapaty
Study Chair
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
06-163
NCT00897702
January 2007
January 2014
Name | Location |
---|---|
Memorial Sloan-Kettering Cancer Center | New York, New York 10021 |
Memorial Sloan-Kettering Cancer Center at Mercy Medical Center | Rockville Centre, New York 11570 |
Memorial Sloan-Kettering at Basking Ridge | Basking Ridge, New Jersey 07920 |
Memorial Sloan-Kettering Cancer Center @ Suffolk | Commack, New York 11725 |
Memoral Sloan Kettering Cancer Center@Phelps | Sleepy Hollow, New York |